Gosset Ownership
Private
Employees
~51
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Lirio General Information
Lirio’s platform has demonstrated success in improving patient engagement, closing gaps in care, and supporting chronic disease management through hyper-personalized digital communications. It is actively used by major health systems such as Cone Health to improve outcomes for diabetes and hypertension patients. No traditional clinical trial results are reported as the company operates a SaaS model focused on population-level behavior change.
Contact Information
Website
Primary Industry
Digital Health Medical Devices
Corporate Office
Knoxville, Tennessee
United States
United States
Drug Pipeline
No pipeline data available
Key Partnerships
Cone Health (strategic partnership for chronic condition interventions), Community Health Network
Lirio Funding
No funding data available
To view Lirio's complete valuation and funding history, request access »